关注
Paul Grootendorst
Paul Grootendorst
Associate Professor, University of Toronto
在 utoronto.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study
PC Austin, P Grootendorst, GM Anderson
Statistics in medicine 26 (4), 734-753, 2007
13282007
The cost of drug development: a systematic review
S Morgan, P Grootendorst, J Lexchin, C Cunningham, D Greyson
Health policy 100 (1), 4-17, 2011
6952011
Coding accuracy of administrative drug claims in the Ontario Drug Benefit database.
AR Levy, BJ O'Brien, C Sellors, P Grootendorst, D Willison
The Canadian journal of clinical pharmacology= Journal canadien de …, 2003
5542003
Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study
PC Austin, P Grootendorst, SLT Normand, GM Anderson
Statistics in medicine 26 (4), 754-768, 2007
2632007
Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey
P Grootendorst, D Feeny, W Furlong
Medical care 38 (3), 290-299, 2000
2562000
Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence
J Lexchin, P Grootendorst
International Journal of Health Services 34 (1), 101-122, 2004
2452004
An empirical analysis of milk addiction
MC Auld, P Grootendorst
Journal of health economics 23 (6), 1117-1133, 2004
1902004
A comparison of alternative models of prescription drug utilization
PV Grootendorst
Health Economics 4 (3), 183-198, 1995
1591995
Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
R Goeree, J Manalich, P Grootendorst, ML Beecroft, DN Churchill
Clinical and Investigative medicine. Medecine Clinique et Experimentale 18 …, 1995
1531995
Dental insurance, income and the use of dental care in Canada
T Bhatti, Z Rana, P Grootendorst
J Can Dent Assoc 73 (1), 57, 2007
1402007
Does it matter whom and how you ask? Inter-and intra-rater agreement in the Ontario Health Survey
PV Grootendorst, DH Feeny, W Furlong
Journal of clinical epidemiology 50 (2), 127-135, 1997
1351997
Estimating the price elasticity of expenditure for prescription drugs in the presence of non‐linear price schedules: an illustration from Quebec, Canada
P Contoyannis, J Hurley, P Grootendorst, SH Jeon, R Tamblyn
Health economics 14 (9), 909-923, 2005
1182005
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
K Jayasundara, A Hollis, M Krahn, M Mamdani, JS Hoch, P Grootendorst
Orphanet journal of rare diseases 14, 1-10, 2019
1122019
Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey
GEJ Faulkner, P Grootendorst, VH Nguyen, T Andreyeva, ...
International Journal of Behavioral Nutrition and Physical Activity 8, 1-14, 2011
1062011
Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research
KM Johnston, P Gustafson, AR Levy, P Grootendorst
Statistics in medicine 27 (9), 1539-1556, 2008
992008
Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment.
P Grootendorst
The Canadian journal of clinical pharmacology= Journal canadien de …, 2002
902002
Becoming the best mom that I can: women's experiences of managing depression during pregnancy–a qualitative study
HA Bennett, HS Boon, SE Romans, P Grootendorst
BMC women's health 7, 1-14, 2007
852007
Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs
PV Grootendorst, LR Dolovich, BJ O'Brien, AM Holbrook, AR Levy
Cmaj 165 (8), 1011-1019, 2001
832001
Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia
JK Marshall, PV Grootendorst, BJ O'Brien, LR Dolovich, AM Holbrook, ...
Cmaj 166 (13), 1655-1662, 2002
802002
Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology
Y Li, MR Abbaspour, PV Grootendorst, AM Rauth, XY Wu
European Journal of Pharmaceutics and Biopharmaceutics 94, 170-179, 2015
792015
系统目前无法执行此操作,请稍后再试。
文章 1–20